Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Damla Ezgi, Barikan"'
Autor:
Ahmet Hakan AKTAŞ, Damla Ezgi BARİKAN
Publikováno v:
Deu Muhendislik Fakultesi Fen ve Muhendislik. 25:329-337
Bu çalışmada, tablet ilaç numunesinde bulunan levadopa ve benserazid etken maddelerinin aynı anda miktar tayinlerine hiçbir ayırma işlemi uygulanmaksızın ultraviyole görünür bölge spektroskopisi ile tayinleri gerçekleştirilmiş ve eld
Autor:
Mehmet Erdogan, Sevim S. Sengul, Bulent Cetin, Mustafa Avcı, Samet Yagci, Ismail Ozkoç, Damla Ezgi Barikan, Mustafa Yildiz
Objective Lutetium-177 (Lu-177) prostate-specific membrane antigen (Lu-177 PSMA) is a novel targeted treatment for patients with metastatic castration-resistant prostate cancer (CRPC). The purpose of the study was to determine the molecular volumetri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3074593c16784d8f7da536ab88780f7c
https://avesis.sdu.edu.tr/publication/details/138c91ca-c9bd-47f0-96e3-e2e2cda0d7bc/oai
https://avesis.sdu.edu.tr/publication/details/138c91ca-c9bd-47f0-96e3-e2e2cda0d7bc/oai
Autor:
Mehmet, Erdogan, Sevim S, Sengul, Bulent, Cetin, Mustafa, Avcı, Samet, Yagci, Ismail, Ozkoç, Damla Ezgi, Barikan, Mustafa, Yildiz
Publikováno v:
Annals of nuclear medicine. 36(6)
Lutetium-177 (LuThese single-center retrospective data were obtained from metastatic CRPC patients receiving intravenous 6.0-8.5 GBq LuIt was found that SUVmax, PSMA TV, and TL PSMA values in bone metastases showed significant differences between the